Anhui Zhifei Longcome Bio-Pharmaceutical Co., Ltd. announced a private placement of common shares for gross proceeds of CNY 500,000,000 on October 18, 2019. The transaction will include participation from returning investor Chongqing Zhifei Biological Products Co.,Ltd. (SZSE:300122), to retain its 100% in the company. Post closing of the transaction, registered capital of the company will increase from CNY 265,000,000 to CNY 765,000,000. The transaction has been approved in the 12th meeting of the 4th directorate of the investor, parent of the company.